Business Context and Reporting Period
This Form 8-K Current Report, filed on February 9, 2023, covers events occurring on February 8 and February 9, 2023, for Intelligent Bio Solutions Inc. (INBS). The filing primarily details the results of the Company's Annual Meeting of Stockholders and the subsequent implementation of a reverse stock split.
Key Financial Metrics and Capital Structure
The filing does not report current period revenue, operating cash flow, or liquidity metrics. However, it provides historical net loss data adjusted for the reverse stock split:
- 12 Months Ended June 30, 2022: Net Loss of $(8,306,051); Post-split Loss Per Share (Basic/Diluted) of $(11.33).
- 12 Months Ended June 30, 2021: Net Loss of $(7,037,286); Post-split Loss Per Share (Basic/Diluted) of $(13.51).
- 3 Months Ended September 30, 2022: Net Loss of $(1,208,293); Post-split Loss Per Share (Basic/Diluted) of $(1.62).
- 3 Months Ended September 30, 2021: Net Loss of $(1,432,652); Post-split Loss Per Share (Basic/Diluted) of $(2.05).
Capital Structure Changes:
- Reverse Stock Split: A 1-for-20 reverse stock split became effective on February 9, 2023, at 4:05 p.m. Eastern Time.
- Share Count Reduction: Outstanding shares decreased from approximately 18,325,289 to approximately 916,265.
- Authorized Shares: Remained at 100 million.
- Par Value: Remained at $0.01 per share.
Material Changes Versus Prior Period
The most significant material change is the reduction in the number of outstanding shares by a factor of 20 due to the reverse stock split. This action was taken to effectuate a change in the Company's capital structure. Additionally, the Company amended its 2019 Long Term Incentive Plan, increasing the aggregate number of shares available for issuance by 1,000,000 shares (from 500,000 to 1,500,000).
Historical financial metrics (Net Loss and Loss Per Share) have been restated on a post-split basis to reflect the new share count, resulting in a significant increase in the reported loss per share figures for prior periods, although the total net loss dollar amounts remain unchanged.
Guidance, Outlook, and Corporate Actions
Corporate Actions Approved:
- Reverse Stock Split: Stockholders approved an amendment to the Articles of Incorporation allowing a split ratio between 1-for-2 and 1-for-35. The Board exercised its discretion to implement a 1-for-20 split.
- Equity Incentive Plan: Stockholders approved an increase of 1,000,000 shares in the 2019 Long Term Incentive Plan.
- Director Elections: Seven director nominees were elected.
- Auditor Ratification: BDO Audit Pty Ltd was ratified as the independent registered public accounting firm.
Trading Information:
- The stock began trading on a split-adjusted basis on February 10, 2023, on The Nasdaq Capital Market.
- The trading symbol remains "INBS".
- A new CUSIP number (36151G402) was assigned.
Adjustments to Derivatives: Proportionate adjustments were made to the exercise prices and share counts of all outstanding stock options, restricted stock units, warrants, and convertible preferred stock.
Risks and Contingencies: The filing notes that no fractional shares were issued; holders entitled to fractional shares received rounding up to the nearest whole number. The filing does not provide specific forward-looking guidance on revenue or profitability.
Investor Verification Checklist
- Share Count Verification: Confirm the post-split share count of approximately 916,265 shares outstanding.
- Trading Symbol and CUSIP: Verify that the ticker remains "INBS" but the CUSIP has changed to 36151G402.
- Option and Warrant Adjustments: Review the specific adjustments to exercise prices and share quantities for any held options, warrants, or RSUs.
- Historical EPS Restatement: Ensure financial analysis tools reflect the restated loss per share figures (e.g., $(11.33) for the year ended June 30, 2022) to avoid valuation errors.
- Proxy Statement Details: Refer to the Schedule 14A filed on January 4, 2023, for full details on the 2019 Plan Amendment and director biographies.